This guide is educational information, not personal medical advice. The source-check date records editorial work, not a clinician review. Read our medical disclaimer.

TB infection and TB disease

Latent TB infection and active TB disease are different situations. People with HIV who have either can be treated effectively, but the evaluation and treatment are not interchangeable. HIV, especially when immune defenses are weakened, increases the likelihood that TB infection progresses to disease.

Tell your HIV team about previous TB tests, exposure, diagnoses and treatment. If you have symptoms or a possible exposure, contact a clinician for assessment and ask what precautions are appropriate while it is being evaluated.

Sources for this section: [1]

What evaluation may involve

A TB blood or skin test can help identify infection. A positive result generally prompts further evaluation to determine whether TB disease is present. Depending on the situation, that evaluation can include an examination, chest imaging or other tests.

A negative test does not always exclude TB, particularly when a person has symptoms or weakened immunity. Do not use this guide to interpret a personal test result; explain any exposure or symptoms to the clinician evaluating you.

Sources for this section: [1]

Coordinating two treatment plans

The clinician chooses a TB plan using information such as the type of TB, drug susceptibility, other health conditions and possible interactions. HIV treatment is also important to TB care. The timing of treatment can depend on the clinical situation, including whether infection involves the brain.

Ask which team is responsible for each prescription and follow-up visit. If different clinicians are involved, give each the same current medication list and ask how they will communicate changes.

Sources for this section: [1]

Check interactions before changes

CDC notes that some TB medicines, including rifampin and rifapentine, have important interactions with many antiretrovirals. A combination that works for one person may not be suitable for another. Include nonprescription products and supplements when the pharmacist checks your list.

Ask what monitoring is planned, what symptoms need a call and whom to reach if either medicine is unavailable. Do not independently change either regimen to solve a suspected interaction.

Sources for this section: [1][2]

Make treatment and follow-up workable

TB treatment can require repeated visits and a plan for taking medicines consistently. CDC describes directly observed treatment and video-based observation as approaches used for TB disease. Ask what arrangements are available, how they fit your schedule and how to report side effects.

Write down the next visit, tests and contact details. If transport, a side effect or a pharmacy problem threatens the plan, tell the appropriate team early so it can help find a practical solution.

Sources for this section: [1]

Why follow-up after a TB test matters

A positive blood or skin test usually indicates TB infection but does not on its own establish whether active disease is present. Additional evaluation may include symptoms, examination, chest imaging and sometimes sputum or other testing. Ask what each step is intended to determine and when you should hear the result.

CDC notes that a negative test cannot always exclude infection or disease, especially if a person has symptoms or a weakened immune system. If symptoms or an exposure were not discussed when the test was ordered, tell the clinician; the result must be considered with the whole clinical picture.

Sources for this section: [1]

If symptoms develop during evaluation

Tell the clinician promptly about a persistent cough, fever, night sweats, weight loss or another symptom that concerns you, particularly after a known TB exposure. TB can affect parts of the body other than the lungs, and the assessment depends on the symptoms and situation.

Ask how to reach the team while results are pending and what to do if you become more unwell. The clinic can advise whether an in-person evaluation is needed and any precautions for attending. A pending or earlier negative test should not keep you from reporting new symptoms.

Sources for this section: [1]

Check the source

Sources & editorial note

We use the sources below to support this guide. Follow a source link for its full guidance and any later changes. Source checking does not replace medical review or a conversation with your care team.

  1. Clinical Care for People with TB and HIV CDC. Accessed .
  2. Drug-Drug Interactions NIH ClinicalInfo. Accessed .

Prepared by HIV Guide editorial team. How we write and check our guides · Contact and corrections information